GCLC and Huntington disease: Meanwhile, luteolin derivatives can also enhance SOD activity, improve the level of glutamate-cysteine ligase catalytic subunit (GCLc) expression, and elevate the mRNA level of GCLc in mutant striatal cells, thereby slowing down or even preventing the progression of HD (Jayawickreme et al., 2024).